Page 5 - Indian Pharma Companies

PLI scheme: Govt looks to get Rs 50,000 crore investments in pharma

The incentive will be in the range of 5-10 per cent of production value, sources said.

US presidential election results may not impact Indian pharma industry

Europe, not India, will be the 1st target if US reduces import dependence: Experts

Covid-19 antigen testing: India next stop for Siemens Healthineers

The investment is part of Siemens Healthineers' strategy 2025, in which India plays an important role as a growth market for the firm.

Covid-19 crisis: India may mobilise pharmacists to administer vaccine

30 million health care workers ready for first phase in January

Repurposing capacity for Covid-19 vaccine, say Indian pharma firms

Suresh Jadhav, executive director of the Serum Institute of India (SII), said the biotechnology company has already put in place an expansion plan for new products in the pipeline

Paracetamol curbs amid Covid-19 pandemic dent sales during monsoon

Sales of paracetamol are typically high during monsoon when cold and flu ailments are common

How India is gearing up its cold chain for Covid-19 vaccine distribution

The expert committee on vaccine administration has initiated talks on cold chain logistics and models that may be required to be adopted

Covid-19 prescription: Pharma players shift their focus over the counter

The pandemic pushes pharma companies to look at drugs that held promise in transitioning to over the counter segment

Are the markets entering a consolidation phase? Here's what charts suggest

Markets started the first trading day of August 2020 lower, with the S&B BSE Sensex slipping over 400 points in intra-day deals

Sanofi India: Sturdy balance sheet, cash-generation augur well for company

High growth visibility in chronics, strong balance sheet will help sustain premium valuation

Trailing in the value chain: Domestic pharma's unfinished agenda

In the first of a 5-part series, we look at reasons keeping Indian pharma sector from becoming the best globally

Adar Poonawalla: A rare risk-taking CEO with strong business acumen

Adar Poonawalla's Serum Institute has tied up with AstraZeneca-backed Oxford vaccine candidate for one billion doses which it will make for India and the GAVI vaccine alliance of 58 countries

Covid-19 crisis: Briton Pharma gets DCGI nod to launch favipiravir

Pune-based Brinton Pharmaceuticals said on Thursday it had got the nod from the Drugs Controller General of India (DCGI) to market its brand Faviton, priced at Rs 59 per tablet

Govt notifies incentive scheme for local API manufacturing to cut imports

According to a government notification, bulk drugs accounted for 63 per cent of total pharmaceutical imports in the country in 2018-19.

We want to price Covid-19 vaccine below Rs 1,000: Serum Institute CEO

Pune's Serum Institute of India is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222

India seeks new preferential treatment from US on drugs, other goods

India accounts for 40 per cent of US generic drug imports, including the anti-malarial hydroxychloroquine, touted by US President Donald Trump in the fight against Covid-19.

Bharat Biotech to Zydus: Seven Indian firms race to develop Covid vaccine

Vaccines normally require years of testing and additional time to produce at scale, but scientists are hoping to develop a coronavirus vaccine within months because of the pandemic

Pharma SMEs will overcome short-term disruptions: CRISIL SME Tracker

Short-term disruptions include high input costs and various operational challenges.

Covid-19 crisis: Race to develop vaccine gets a booster as field widens

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.

China crisis, India scouting for APIs a shot in arm for sick pharma PSU

Govt is trying to reduce dependence on China for APIs and develop indigenous sources